Global Foley Catheters Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight

The growing demand for Foley catheters is driven by several important factors. Firstly, the rising global aging population is contributing to a higher incidence of conditions like urinary retention, incontinence, UTIs, urinary stone disease, bladder cancer, and BPH, all of which often require Foley catheters for urinary drainage. Moreover, advancements in medical technologies and procedures have broadened the uses of Foley catheters, making them a critical tool in various healthcare environments, including hospitals, nursing homes, and home care settings.

/EIN News/ -- New York, USA, May 22, 2025 (GLOBE NEWSWIRE) -- Global Foley Catheters Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~9% by 2032 | DelveInsight

The growing demand for Foley catheters is driven by several important factors. Firstly, the rising global aging population is contributing to a higher incidence of conditions like urinary retention, incontinence, UTIs, urinary stone disease, bladder cancer, and BPH, all of which often require Foley catheters for urinary drainage. Moreover, advancements in medical technologies and procedures have broadened the uses of Foley catheters, making them a critical tool in various healthcare environments, including hospitals, nursing homes, and home care settings.

DelveInsight’s Foley Catheters Market Insights report provides the current and forecast market analysis, individual leading Foley catheters companies’ market shares, challenges, Foley catheters market drivers, barriers, trends, and key market Foley catheters companies in the market.

Key Takeaways from the Foley Catheters Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global Foley catheters market during the forecast period. 
• In the product type segment of the overall Foley catheters market, the 2-way category held the largest share in the year 2024.
• Notable Foley catheter companies such as ANGIPLAST PRIVATE LIMITED., BD, Cardinal Health, HEMC (Hospital Equipment Manufacturing Company), Advin Health Care, AdvaCare Pharma, Teleflex Incorporated, GWS Surgicals LLP, BACTIGUARD AB, Medtronic plc, Convatec Inc., B. Braun, Ribbel International Limited, Coloplast, Sterimed Group, Suzhou Sunmed Co., VOGT MEDICAL, Boston Scientific Corporation, Cook, Smiths Group plc, and several others are currently operating in the Foley catheters market.
• In December 2024, InnoCare Urologics announced that it had obtained FDA 510(k) approval for its innovative urinary safety catheter.
• In June 2024, Silq Technologies revealed that its ClearTract® Foley Catheter has been awarded an Innovative Technology contract by Vizient, Inc., the largest healthcare performance improvement organization in the country, driven by providers.
• In December 2023, Bactiguard Holding AB announced an enhanced partnership with Becton Dickinson & Company (BD), a prominent global medical technology company.
• In December 2023, HR Pharmaceuticals, Inc. (HRP) secured an Exclusive Commercial Agreement with Poiesis Medical LLC to license Poiesis's Dual Balloon Catheters (Duette™).

To read more about the latest highlights related to the Foley catheters market, get a snapshot of the key highlights entailed in the Global Foley Catheters Market Report

Foley Catheters Overview

Foley catheters are flexible tubes inserted into the bladder to drain urine, commonly used in medical settings for patients who are unable to urinate naturally due to surgery, illness, or injury. Named after Dr. Frederic Foley, who designed them in the 1930s, these catheters are typically made of latex or silicone and feature an inflatable balloon at the tip. Once the catheter is inserted through the urethra into the bladder, the balloon is inflated to keep it securely in place. Foley catheters are classified as indwelling, meaning they remain in place for extended periods, unlike intermittent catheters, which are used temporarily.

These catheters are essential tools in critical care, urology, and postoperative recovery, helping monitor urine output and manage conditions such as urinary retention or incontinence. However, prolonged use can increase the risk of complications like urinary tract infections (UTIs), bladder spasms, or urethral damage. To minimize these risks, medical professionals follow strict protocols for insertion, maintenance, and timely removal. Innovations in catheter design and materials continue to improve patient comfort and reduce infection rates.

Foley Catheters Market Insights

North America is anticipated to dominate the global Foley catheters market in the coming years. This is primarily due to the region's large aging population, which is more prone to urological issues that require urinary catheterization, such as urinary retention, incontinence, benign prostatic hyperplasia (BPH), urinary stone disease, and bladder cancer. Additionally, improvements in healthcare infrastructure, technology, and procedures have expanded the uses of Foley catheters, making them crucial in various medical environments. These factors collectively contribute to the increasing demand for Foley catheters in North America.

Surgical procedures for urinary stone disease, such as ureteroscopy, percutaneous nephrolithotomy (PCNL), or shock wave lithotripsy (SWL), often require Foley catheters to manage urine flow during and after the surgery, as well as to monitor potential complications like bleeding or blockages from stone fragments. The growing prevalence of urolithiasis is expected to further fuel the demand for Foley catheters in North America.

Moreover, recent mergers, acquisitions, and partnerships among key market players, such as the expanded collaboration between Becton, Dickinson and Company (BD) and Bactiguard AB, are also expected to influence the market. In December 2023, Bactiguard announced an enhanced partnership with BD, granting BD an exclusive global license for Bactiguard-coated Foley catheters. This partnership is part of Bactiguard's broader strategy to shift away from its medical device portfolio. Together, these developments are likely to support the growth of the Foley catheter market in North America from 2025 to 2032.

To know more about why North America is leading the market growth in the Foley catheters market, get a snapshot of the Foley Catheters Market Outlook 

Foley Catheters Market Dynamics

The Foley catheter market has been witnessing steady growth in recent years, driven by the increasing incidence of urinary retention, surgeries, and various medical conditions that require prolonged urinary drainage. Foley catheters are widely used in hospitals and healthcare facilities for patients undergoing surgical procedures, those with urinary incontinence, or individuals with neurogenic bladder. The rising global geriatric population, along with a growing prevalence of chronic conditions such as diabetes, which can lead to urinary retention, is significantly driving the demand for Foley catheters. This increasing patient pool creates a sustained market need for these medical devices.

The market is also being propelled by advancements in catheter technology, such as the introduction of silicone-coated catheters, antimicrobial coatings, and hydrophilic catheters that minimize the risk of infections and improve patient comfort. As hospitals and healthcare facilities seek to improve patient care while reducing complications related to catheter use, these innovations have proven to be essential in enhancing both safety and effectiveness. Additionally, the rise in home care services and outpatient treatments, especially in developed markets, has expanded the application of Foley catheters beyond hospitals to home care settings, further expanding the market scope.

However, the Foley catheter market is not without challenges. One of the major issues is the risk of urinary tract infections (UTIs) associated with prolonged catheter use, which has led to increasing scrutiny over catheter-related complications. This has prompted regulatory bodies to establish more stringent standards for their manufacture and use. Additionally, concerns about the environmental impact of disposable catheters have spurred interest in developing biodegradable and eco-friendly alternatives, though the adoption of these materials is still in its nascent stages.

Overall, the Foley catheter market is poised for steady growth, driven by demographic shifts, medical advancements, and evolving healthcare landscapes. The combination of technological innovation, increasing healthcare demand, and the need for safer, more efficient products will continue to shape the dynamics of this market in the future.

Get a sneak peek at the Foley catheters market dynamics @ Foley Catheters Market Dynamic Analysis 

Report Metrics	Details
Coverage	Global
Study Period	2022–2032
Foley Catheters Market CAGR	~9%
Foley Catheters Market Size by 2032	USD 2.38 Billion
Key Foley Catheters Companies	ANGIPLAST PRIVATE LIMITED., BD, Cardinal Health, HEMC (Hospital Equipment Manufacturing Company), Advin Health Care, AdvaCare Pharma, Teleflex Incorporated, GWS Surgicals LLP, BACTIGUARD AB, Medtronic plc, Convatec Inc., B. Braun, Ribbel International Limited, Coloplast, Sterimed Group, Suzhou Sunmed Co., VOGT MEDICAL, Boston Scientific Corporation, Cook, Smiths Group plc, among others

Foley Catheters Market Assessment

• Foley Catheters Market Segmentation
  • Foley Catheters Market Segmentation By Product Type: 2-Way, 3-Way, and 4-Way
  • Foley Catheters Market Segmentation By Material: Silicone, Latex, and Others
  • Foley Catheters Market Segmentation By Applications: Bladder Cancer, Urinary Stone Disease, Prostate Conditions, and Others
  • Foley Catheters Market Segmentation By End User: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • Foley Catheters Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the Foley catheters market are set to emerge as the trendsetter explore @ Foley Catheters Companies 

Table of Contents 

1	Foley Catheters Market Report Introduction
2	Foley Catheters Market Executive Summary
3	Competitive Landscape
4	Regulatory Analysis
5	Foley Catheters Market Key Factors Analysis
6	Foley Catheters Market Porter’s Five Forces Analysis
7	Foley Catheters Market Layout
8	Foley Catheters Market Company and Product Profiles
9	KOL Views
10	Project Approach
11	About DelveInsight
12	Disclaimer & Contact Us

Interested in knowing the Foley catheters market by 2032? Click to get a snapshot of the Foley Catheters Market Trends

Related Reports

Urinary Tract Infection Testing Devices Market

Urinary Tract Infection Testing Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key urinary tract infection testing devices companies, including F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, ACON Laboratories, Inc., Cardinal Health, Sysmex Corporation, Abbott, Siemens Healthcare Private Limited, Laboratory Corporation of America® Holdings, Randox Laboratories Ltd., Vivoo, QIAGEN, bioMérieux SA, PIRAMAL PHARMA LIMITED, Healthy.io, among others.

Urinary Tract Obstruction Treatment Devices Market

Urinary Tract Obstruction Treatment Devices Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key urinary tract obstruction treatment devices companies, including B. Braun Melsungen AG, Boston Scientific Corporation, Cook, Becton, Dickinson, and Company, Teleflex Incorporated, Olympus, Dornier Medtech, EMS Urology, Advin Health Care, Inceler Medikal Co. Ltd., STORZ MEDICAL AG, Shockwave Medical Inc., ACE Medical Devices Pvt. Ltd., Walz Elektronik GmbH, Applied Medical Resources Corporation, Richard Wolf GmbH, Stryker, Urocare Products, Inc., J and M Urinary Catheters LLC, Rocamed, among others.

Non-Muscle Invasive Bladder Cancer Market

Non-Muscle Invasive Bladder Cancer Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key NMIBC companies, including UroGen Pharma, Pfizer, Roche, CG Oncology, ImmunityBio, Theralase, enGene, SURGE Therapeutics, Aura Biosciences, UroGen Pharma Ltd., FKD Therapies Oy, ImmunityBio, Inc., Protara Therapeutics, Janssen Research & Development, LLC, Tyra Biosciences, Inc, among others.

Complicated Urinary Tract Infections Market

Complicated Urinary Tract Infections Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key complicated urinary tract infections companies, including Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics, Meiji Seika Pharma, Fedora Pharmaceuticals, Evopoint Pharmaceuticals, among others.

Uncomplicated Urinary Tract Infection Market

Uncomplicated Urinary Tract Infection Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key uncomplicated urinary tract infection companies, including GlaxoSmithKline, Locus Biosciences, Inmunotek, among others.

DelveInsight’s Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.

Other Business Pharmaceutical Consulting Services

Healthcare Conference Coverage

Pipeline Assessment

Healthcare Licensing Services

Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  

Contact Us
                    
                    Shruti Thakur 
                    
                    info@delveinsight.com 
                    
                    +14699457679